Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Total Current Liabilities

All obligations due within one year.

No reported Total Current Liabilities figures are available to summarize.

Total Current Liabilities history

Currency unavailable · from the balance sheet

No Total Current Liabilities data reported for this period type.

Total Current Liabilities vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Total Current Liabilities for SPTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
VNDAVanda Pharmaceuticals Inc.Mar 2026$135.58M USD+30.5%+16.7%31.3%
NMRANeumora Therapeutics, Inc. Common StockMar 2026$30.12M USD+6.1%+11.0%19.6%
RAPPRapport Therapeutics, Inc. Common StockMar 2026$17.9M USD+90.7%+125.4%3.6%
MPLTMapLight Therapeutics, Inc.Mar 2026$14.28M USD+10.0%+8.8%3.4%
GHRSGH Research PLCMar 2026$11.82M USD+19.1%+22.6%4.3%
LBRXLB Pharmaceuticals Inc Common StockMar 2026$10.91M USD+179.2%+151.3%2.8%
CTNMContineum Therapeutics, Inc. Class A Common StockMar 2026$6.66M USD-25.6%+8.9%2.5%
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+19.1%+16.7%3.6%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.